This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the biotech industry. Sign up here to get it delivered to your inbox. Spain is amazing. I was in Madrid for five days covering the ESMO conference. Now, I’m delivering this newsletter to you from a balcony overlooking the Mediterranean. Vertex kidney disease drug scrutinized for infection risk ahead of FDA approval decision So many medical meetings, so little time. While I was in Madrid reporting on cancer drugs, kidney disease specialists and the investors and analysts who tag along were in Denver for the annual meeting of the American Society of Nephrology. Continue to STAT+ to read the full story…
CryptoAlerta — análise de criptomoedas e mercado em tempo real